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Abstract 
Immunizing children could reduce influenza in the elderly. We compared pneumonia and influenza hospitalizations (P&I) and 
medically attended acute respiratory infections (MAARI) in the Medicare populations in 1 Tennessee and 3 Minnesota counties that
immunized school children with live, attenuated influenza vaccine with 4 comparison counties.  The P&I rate ratio (RR) of 
intervention county/comparison county in Tennessee in 2005-06 was 0.74 (95% CI 0.61 – 0.87 which was significantly lower than 
the previous 5 years.  With low influenza activity in 2006-07, P&I RRs for both states were not lower than the pre-intervention
years. MAARI RRs in both states did not differ from the pre-intervention periods.  Immunizing children against influenza may 
reduce P&I for the elderly in seasons when influenza outbreaks are severe.  Additional study is needed before immunizing children 
against influenza can be recommended for herd immunity. 
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1. Introduction 
Immunizing school children has been proposed as a strategy both for protecting the elderly and other high risk 
persons against seasonal influenza and controlling pandemic influenza.  While school-based vaccination programs will 
directly protect vaccinated children and may indirectly protect their families as well as classmates and their families 
(1-5), stronger evidence is needed before this strategy can be recommended for community-level protection.  One 
county health department in Tennessee conducted school-based influenza immunization projects in 2005 and 2006. (6)  
Three local health departments in Minnesota immunized school children in their counties in 2006. (7)  Because 
relatively high coverage was achieved in both programs, we examined Medicare data from these states to determine if 
pneumonia and influenza (P&I) hospitalizations or medically attended acute respiratory illness (MAARI) among 
persons 65 years of age and older were reduced in counties where a significant percentage of school children were 
vaccinated against influenza. 
2. Background   
2.1. Immunization Programs 
In the autumn of 2005, the Knox County (Tennessee) Health Department immunized 24,198 of 53,420 public school 
children (45%) with one or more doses of live attenuated influenza vaccine (LAIV, MedImmune, Gaithersburg, MD). 
In 2006, 25,749 of 54,786 public school children (47 %) were vaccinated with at least one dose of LAIV, as were 3,659 
of 5,998 (61%) of private school children. In the autumn of 2006, the Lyon, Mower and Stearns County Health 
Departments in Minnesota organized school-based immunization programs, offering free doses of LAIV to children 
attending all schools, both public and private, in their counties. Overall, 41% of 38,566 school children were vaccinated 
in the 3 counties combined.  Details of the immunization programs have been previously published. (6, 7)   National 
surveillance data show that A(H3N2) influenza viruses were the predominant strain during the 2005-2006 season and 
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3. Methods 
3.1. Data sources 
Study eligibility, health service utilization, and influenza vaccination information for elderly Minnesota and 
Tennessee residents was obtained from Medicare administrative data maintained by the Centers for Medicare and 
Medicaid Services (CMS). Eligible beneficiaries were identified using the annual Denominator files for 2000-2006. 
Hospitalizations for P&I among elderly Medicare fee-for service beneficiaries were identified in the annual MedPAR 
hospitalization files for 2000-2007. Physician office visits for MAARI were identified using the annual Carrier files.  
Evaluation and management visits and visits to emergency rooms for MAARI were identified using the Outpatient file. 
The Carrier file is the Medicare claims file that contains claims submitted by physicians for office visits, as well as 
most other services covered by Medicare Part B. Influenza vaccinations were identified using the annual Carrier and 
Outpatient files. ICD-9-CM codes for MAARI have been previously published elsewhere. (10) 
3.2. Study cohort source and definition 
The study population was persons 65 to 99 years of age who were enrolled in the Medicare fee-for-service program 
and resided in the MN and TN intervention and comparison counties as defined by the Medicare Denominator files for 
2000 through 2006.  To be eligible for inclusion in each year of the study, the person had to be enrolled in both 
Medicare Part A and Medicare Part B, not be enrolled in a Medicare Advantage health plan and not have end-stage 
renal disease during December of the influenza period.  
3.3. Elderly Influenza Immunization Information 
Influenza vaccination rates among elderly Medicare fee-for-service beneficiaries were calculated for each of the 
years, 2000 through 2006, based on Medicare claims for influenza vaccine or influenza vaccine administration received 
2.2. Counties 
Knox County in eastern Tennessee was the intervention (I) county in that state.  It consists of Knoxville and 
surrounding communities.  Davidson County was the comparison (C) county. It is located in north central Tennessee, 
encompassing Nashville and surrounding communities.  In Minnesota, the 3 intervention counties were:  Lyon, located 
in southwestern Minnesota with Marshall as county seat; Mower, located in southern Minnesota with Austin as county 
seat; and Stearns, located in central Minnesota with St. Cloud as county seat. One comparison county was selected for 
each of the 3 Minnesota intervention counties.  Comparison counties were selected as being similarly rural or urban, 
not geographically contiguous with the intervention counties, and participating in the state’s influenza surveillance 
program. These comparison counties were: Blue Earth, located in south central Minnesota with Mankato as county 
seat: Crow Wing, located in north central Minnesota with Brainerd as county seat: and Douglas, located in central 
Minnesota with Alexandria as the county seat.  Selected demographic characteristics of each county are found in 
Table 1. 
Table 1. Selected Demographic Characteristics of Study Counties 
County 
2007
Population 
%
> 65 yrs 
%
< 18 yrs 
%
White
%
Black 
%
Hispanic 
Per Capita  
Income 
Tennessee  
Knox  423,874 12.7 22.3 88.1 8.6 1.3 $21,875  
Davidson  619,626 11.1 22.2 67 25.9 4.6 $23,069  
Minnesota  
Lyon  24,940 14.6 26.2 93.6 1.5 4.0 $18,013  
Mower 38,423 19.6 25.1 94.7 0.6 4.3 $19,795  
Stearns  145,877 11 25.7 96 0.8 1.4 $19,211  
Blue Earth  59,723 12.1 21.4 95 1.2 1.8 $18,712  
Crow Wing  61,390 17.1 23.8 97.6 0.3 0.7 $19,174  
Douglas  35,827 17.9 24 98.5 0.2 0.6 $18,850  
A(H1N1) were predominant 2006-2007 influenza seasons but A(H3N2) viruses circulated late in the season.  
Circulating strains matched the strains in the vaccine closely in both years. (8, 9)  
94  Harry F. Hull et al. / Procedia in Vaccinology 2 (2010) 92–100
3
between September 1 and December 31 using the Medicare Carrier and Outpatient files. The influenza vaccine and 
vaccination codes used to identify vaccinated persons are in Appendix A.  
Hospitalizations for P&I for each flu season were identified in the Medicare MedPAR files for 2000-2007 using 
ICD-9-CM codes 481-487.x. Readmissions occurring within 14 days were not included. Initial analyses compared P&I 
hospitalization rates by county based on P&I diagnoses in the primary diagnosis position only versus P&I in all 10 
available diagnosis positions. The percent of hospitalizations in the secondary positions generally increased in all 
counties during the study period, although not in a linear fashion. In addition, the temporal fluctuations and changes in 
these rates were not similar in the intervention and control counties in the respective states. Further, because the effect 
of vaccination-induced reduction on circulation of the influenza virus should affect rates of community-acquired P&I, 
we felt that this would be better represented by P&I diagnoses recorded in the primary position.  Thus, we present rates 
only for the results of P&I in the primary position.  
MAARI events occurring during the flu season were identified using the Medicare Carrier and Outpatient files. 
MAARI events were limited to those that occurred in physician offices, outpatient evaluation and management visits, 
and outpatient emergency rooms. Because multiple claims could be submitted for a MAARI event, second MAARI 
events were counted only if they occurred more than 7 days after the initial event. 
3.4. Influenza Seasons 
Influenza seasons were defined using influenza virus isolation data provided by the state laboratory (MN) and 
information collected either by the state laboratory (2000-2002) or rapid influenza test information from health care 
institutions (2003-2007) (TN) (4). In MN, funds had been provided to the intervention and comparison counties by the 
state to encourage increased influenza virus surveillance, but there was no evidence that this resulted in increased 
reporting from these areas. The great majority of isolates in MN were from the 7 county Twins Cities metropolitan area 
that did not include any of the study counties. Based on the MN information, periods of influenza activity were defined 
as the first week with 10 or more isolates, followed by 2 weeks with 10 or more isolates through the last week with 10 
or more isolates that was followed by 2 weeks with the number of isolates less than 10. In TN, the influenza seasons 
were considered to begin on the week when the cumulative proportion of positive rapid influenza tests observed during 
fall/winter attained 2.5%. The season was deemed to end on the week when the cumulative proportion reached 97.5% 
(4).  The dates of the influenza seasons are shown in Table 2. 
Table 2. Periods of Influenza Virus Activity MN and TN, 2000-01 through 2006-07  
 Minnesota  Tennessee  
Season Period Weeks Period Weeks 
2000-01 12/31 - 3/17 11 12/24 - 3/3 10 
2001-02 1/20 - 4/27 14 1/13 - 3/30 11 
2002-03 1/26 - 4/19 12 12/15 - 3/15 13 
2003-04 11/30 – 3/4 14 11/2 - 1/10 10 
2004-05 12/12 – 4/2 16 12/19 - 3/19 13 
2005-06 1/1 - 4/22 16 1/1 - 4/22 16 
2006-07 12/24 - 3/10 11 12/10 - 3/17 14 
3.5. Data Analysis 
Crude and age-adjusted P&I hospitalization rates per 1,000 eligible beneficiaries and MAARI rates per 100 eligible 
beneficiaries  for the intervention and comparison counties were calculated for each influenza season 2000-01 through 
2006-07.  We then calculated the ratio of these rates between the intervention and the comparison counties for each 
season. A rate ratio (RR) with 95% confidence intervals (CI) was calculated as an approximation of the relative risk. A 
RR of 1 indicated similar influenza-related outcomes in the intervention and the comparison counties. CIs 
encompassing 1 indicated no significant difference in the outcome rates between the intervention and comparison 
county populations. (4) In addition, the RRs for intervention years were compared with the RR for the combined pre-
intervention years (2000-01 to 2004-05 in TN and 2000-01 to 2005-06 in MN) using the z test on the log RRs and p 
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values assigned based on the z score (11,12). If the standard error for an intervention year did not lie within the 
standard error for the combined pre-intervention seasons, we considered RR for the intervention period to be 
significantly different from the RR for pre-intervention period.
4. Results 
In Tennessee, annual immunization rates for the study population for the years 2000 through 2006 ranged from 
27.4-59.4% with a median rate of 54.5% in Knox County and 40.4-53.3% with a median of 49.8% in Davidson County.  
Immunization rates in Knox County were 59.4% and 56.8% in 2005 and 2006 respectively.  In Davidson County, 
immunization rates were 51.8% and 53.3% in 2005 and 2006 respectively.  In Minnesota, immunization rates for the 
intervention populations for the years 2000-2006 ranged from 56.4-65.6% with a median rate of 61.0% in the 3 
intervention counties and 61.3-66.5% with a median of 63.9% in the comparison counties.  In 2006, the immunization 
rate for the 3 intervention counties combined was 61.6% and 64.8% in the 3 comparison counties.  None of these 
differences in immunization rates was statistically significant with the exception of 2004 (a year of vaccine shortage) in 
Tennessee, when immunization rates were 46% in Davidson County and 27.4% in Knox County.  
Figure 1.  Age-adjusted rates of P&I hospitalizations and rate ratios, Tennessee, 2000/01-2006/07. 
In TN, the age-adjusted hospitalization rates for P&I were lower in Knox County (I) than in Davidson County (C) 
for all years during the 5 year pre-intervention period.  (Fig. 1) The RRs (I/C) were consistently <1. In all but one year 
(2003-04) the 95% CI included 1; thus, the annual differences between the counties were generally not statistically 
significant. During the 2005-6 influenza season (the first intervention year), the rate of P&I hospitalizations fell more 
sharply in Knox County than in Davidson County, resulting in a RR of 0.74 (95% CI 0.61, 0.87). This RR was 
significantly below the RR for the 5 pre-intervention years (RR, 0.87; 95% CI 0.80 - 0.94), p = 0.042.  During the 
2006-07 influenza season, P&I hospitalization rates continued to fall in both counties, but Davidson fell more sharply.  
The resulting RR was, 0.920 (95% CI 0.74, 1.10), which was not significantly different from the RR for the 5 pre-
intervention years (p = 0.320).  
The age-adjusted hospitalization rates for P&I in Minnesota in both intervention and comparison counties were 
closely parallel over the 6 years preceding the school immunization program. (Fig. 2)  During the 2006-07 influenza 
season, the rates of P&I hospitalization fell sharply in both intervention and comparison  counties  to  the  lowest  levels  
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Figure 2. Age-adjusted rates of P&I hospitalizations and rate ratios, Minnesota, 2000/01-2006/07. 
seen during the study period with the exception of 2000-01 in the intervention counties. However, the decline was 
greater in the comparison counties than in the intervention counties. The resulting RR (I/C) for 2006-07 of 1.49 (95% 
CI 1.03, 1.95) was > 1, and it was significantly greater than the mean RR of 1.07 (95% CI .98, 1.17)) for the 6 pre-
intervention years (p = 0.026).   
The age-adjusted MAARI rates for both Tennessee and Minnesota are shown in Figures 3 & 4.   The RRs for 
MAARI were relatively constant during the entire study period in both states. In MN, the RR was consistently less 
than 1, and in TN it was consistently greater than 1.  There were no significant differences in the RRs between the 
intervention years and the combined baseline years (p values between 0.300 and 0.716).  
5. Discussion 
Influenza is a major cause of morbidity and mortality among persons with high-risk medical conditions, the elderly 
and young children.   Although influenza vaccination rates in persons over age 65 have risen significantly over the last 
2 decades and are now estimated to be 72% in the US (13), there has not been a comparable reduction in 
hospitalizations and deaths. (14, 15) While vaccines with better immunogenicity are a possible solution for reducing 
the impact of influenza on high-risk populations (16), another potential strategy is to protect them indirectly through 
herd immunity.  As school children are among the first members of the community to be infected and are efficient 
transmitters of influenza (17), vaccinating this population might reduce the spread of influenza in the community, 
thereby reducing the potential for high-risk persons to be exposed to influenza virus and become ill. (18)  In addition, 
modeling has suggested that vaccinating school children could stop the spread of pandemic influenza. (19)   School-
located immunization programs are attractive because they have the potential to reach large numbers of children 
rapidly and at low cost. (20, 21) 
Immunization of school children reduced both P&I and all-cause mortality among the elderly in Japan over a period 
of decades when the elderly were not routinely immunized. Mortality rose sharply when the national immunization 
program was discontinued in the 1990’s. (22)   A demonstration project in Michigan in 1968 found that the influenza 
attack rate was 22% lower in a single community where more than 85% of school children were vaccinated when 
compared with a single comparison community. (23)  A study in Russia found that influenza rates in the unvaccinated 
elderly were reduced in communities where school children had been immunized. (24)  Immunization of 20-25% of 
school-aged children in Texas over a 3 year period reduced MAARI in the intervention communities by 8-18%. (10)  
While annual immunization of school-aged children has recently been recommended in the US, (25, 26) this was for 
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the direct benefit to the immunized child. There is a need for additional scientific evidence before immunization of 
school children can be recommended to provide community level protection. (27) 
A prospective, scientifically valid study of the effects of immunizing school children protecting other populations 
from influenza in the US might require that randomly selected states conduct school-located immunization programs 
over a period of years with a comparison of morbidity and mortality among high-risk persons.   Not only would this be 
difficult and expensive, but the opportunity to do so in the US has been lost because of the recommendation for routine 
immunization of school children and the likely use of school-located immunization programs as one of the primary 
strategies for protecting the population from the H1N1 pandemic.  This study was an attempt to provide additional 
scientific evidence for herd immunity-based approaches to influenza control. 
Our study found a significant reduction in the P&I hospitalization rate among the elderly during the influenza season 
following the first year of a county-level school-located influenza immunization program (2005-06) in TN compared 
with the pre-intervention period.   However, there was no reduction in the P&I hospitalization rate during the influenza 
season following the second year of the program (2006-07).  An analysis of laboratory-confirmed influenza 
hospitalizations in these same counties for the 2006-07 season similarly found that rates were not reduced for persons 
65 years of age and older.  They did, however, find a reduction for persons 50-64 years of age. (28)  In MN, there was 
no reduction in the P&I hospitalization rate during the 2006-07 influenza season following the intervention in the fall 
of 2006.  The MN hospitalization rates fell sharply, but more so in the comparison counties than the intervention 
counties.  Consequently, the RR was significantly greater in MN when compared to the baseline period.  Nationally, 
the 2006-07 influenza season was characterized by low levels of influenza virus circulation with the predominant virus 
being similar to the 2005-06 virus so that it is likely that in TN and MN the immunity in the elderly population would 
have been high both through prior vaccination and exposure to circulating virus the prior year.  Our findings suggest 
that immunization of school children could reduce influenza related hospitalizations among high-risk elderly persons, 
but only during years when the influenza virus is antigenically dissimilar to previously circulating viruses and/or the 
level of circulating virus is high.  
We found that immunizing school children had no effect on MAARI in the Medicare population.  Our findings 
contrast with those of Piedra, who found an 8-18% reduction in MAARI for persons 35 years of age and older 
associated with immunizing 20-25% of school children in Texas. (10)  The absence of a detectable effect on MAARI is 
perplexing in light of the higher immunization rates achieved in MN and TN.  
Our finding of reduced P&I hospitalizations among the Medicare population should be interpreted with caution.  We 
found the reduction only in one year and in one state.  The effect was not present in either state during the season when 
influenza activity was low. Because influenza seasons are highly variable, additional years should be studied to validate
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our finding.  In the years we studied, there was over a 2-fold difference in the rates of P&I hospitalizations and 
MARRI. Our comparison sites were also not randomly selected. Ideally, a larger intervention population would be 
studied and both intervention and study sites randomized.  We also analyzed the data at the county level so that our 
analysis was relatively insensitive.   An analysis at the individual level using vaccination status as recorded in the 
Medicare databases, as well as other personal, clinical and health service utilization information, would allow a more 
sensitive analysis.  Our outcome measures are also non-specific.  Both P&I and MAARI include a substantial 
percentage of events that are not caused by influenza virus, even during influenza season.  Using laboratory-confirmed 
cases would increase the reliability of the analysis, but would substantially reduce the number of cases included in the 
analysis as well as increasing the cost and difficulty of conducting a study.  Finally, our study populations were highly 
immunized with more than 50% of individuals with vaccinations reimbursed by Medicare in most years.  It is likely 
that vaccination coverage is still higher as CDC’s Behavioral Risk Factor Surveillance System reported that 80.9% 
(MN) and 71.0% (TN) of persons 65 years of age and older were immunized against influenza during the 2006-07 
influenza season. (11)  High levels of vaccination among the elderly could have made it more difficult to detect any 
effect in our relatively small study populations.  
In summary, we have detected a statistically significant, one year reduction in P&I hospitalizations in the Medicare 
population associated with a public program to immunize school children against influenza in Tennessee.   No 
reduction in hospitalizations was found in association with the second year of that program or school immunization 
programs in Minnesota during a year when influenza activity was low. The limitations of our study methodology make 
our findings suggestive, rather than definitive.  Additional studies should be conducted with larger populations over a 
longer period of time using a more refined methodology so that the question of whether vaccinating school-aged 
children against influenza provides community-level protection can be answered conclusively. 
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Appendix A 
Codes for Influenza Vaccination 
ICD-9 Code 
V04.81  Need for prophylactic vaccination against influenza 
HCPCS Codes 
G0008 Administration of influenza virus vaccine 
G8108 Patient documented to have received influenza vaccination during 
influenza season (for patients age 50 and older) 
90656 Influenza virus vaccine, split virus, preservative free, when administered  
  to 3 years and older, for intramuscular use 
90658 Influenza virus vaccine, when administered to 3 years and older, for  
  intramuscular use 
90659 Influenza virus vaccine, whole virus, for intramuscular or jet injection use 
90660 Influenza virus vaccine, live, for intranasal use 
